Evaluation of a Trauma-Informed Partner Violence Intervention Program
Launched by BOSTON UNIVERSITY · Jan 27, 2025
Trial Information
Current as of June 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying two different programs designed to help men who have been involved in intimate partner violence (IPV) and their partners. The first program, called Strength at Home (SAH), focuses on trauma-informed care, while the second is a standard intervention program known as Treatment as Usual (TAU). The researchers want to see which program is more effective in reducing both physical and emotional violence in relationships. They will also look at how these programs affect symptoms of post-traumatic stress disorder (PTSD), feelings of confusion about emotions (alexithymia), problems with alcohol use, and overall satisfaction with the treatment.
To participate in this study, men must be court-mandated to attend an IPV intervention program in Rhode Island, and they can bring their partners into the study as well. Participants can expect to be part of a randomized controlled trial, meaning they will be assigned by chance to one of the two programs. This trial is currently not recruiting participants, but it aims to understand which approach may offer better support for both men and their partners in overcoming the challenges related to IPV.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Men court-mandated to IPV intervention from the Rhode Island Department of Parole and Probation and their partners
- Exclusion Criteria:
- • None
About Boston University
Boston University, a leading research institution located in Boston, Massachusetts, is dedicated to advancing health sciences through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing health challenges. Boston University is committed to ethical research practices, patient safety, and the dissemination of findings to foster greater understanding and advancements in medical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Boston, Massachusetts, United States
Patients applied
Trial Officials
Casey T Taft, PhD
Principal Investigator
CABU School Medicine, Psychiatry
Lindsay Orchowski, PhD
Principal Investigator
Rhode Island Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported